NCT00534300View on ClinicalTrials.gov

Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Ventricular TachycardiaSudden Cardiac Death
Interventions
DRUG

Omegaven

Lipid emulsion (omegaven) for intravenous use, 100 ml (25 mL/h)

DRUG

Isotonic saline

Intravenous infusion, 100 mL, 25mL/h

Trial Locations (1)

9000

Department of Cardiology, Aalborg Hospital, Aalborg

All Listed Sponsors
lead

Aalborg University Hospital

OTHER

NCT00534300 - Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker | Biotech Hunter | Biotech Hunter